Clinical trial
Comparison of Teicoplanin and Vancomycin in Initial Empirical Antibiotic Regimen…
NCT00454272 · Sanofi, Industry · Completed
Key facts
| NCT number | NCT00454272 |
|---|---|
| Title | Comparison of Teicoplanin and Vancomycin in Initial Empirical Antibiotic Regimen for Febrile Neutropenic Patients |
| Official title | Comparison of Teicoplanin and Vancomycin in Initial Empirical Antibiotic Regimen for Febrile Neutropenic Patients |
| Lead sponsor | Sanofi, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Infection, Febrile Neutropenia |
| Intervention type | Drug |
| Interventions | Teicoplanin, Vancomycin |
| Enrollment | 197 |
| Start date | Jan 1, 2005 |
| Primary completion | Aug 1, 2007 |
| Completion | Aug 1, 2007 |
| First posted | Mar 30, 2007 |
| Last update posted | Mar 6, 2009 |
| Countries | Turkey (Türkiye) |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: